CME Webinar Series Guides Clinicians on Individualizing HER2-Positive Breast Cancer Treatment

Individualizing human epidermal growth factor receptor 2 (HER2) is the focus of a series of live continuing medical education (CME) guidance webinars launched by Rockpointe and the Potomac Center for Medical Education. The free series for clinicians is CME, Certified Nurse Educator and American Board of Internal Medicine maintenance of certification-certified. Participants, upon completion, should be skilled in evaluating safety and effectiveness of currently approved HER2-positive metastatic breast cancer (MBC) treatments; developing tailored treatment plans for patients with progressive HER2-positive MBC; assessing patients with breast cancer for HER2 expression level; and discussing emerging treatments for HER2 low expression MBC.

Read More